Title: Is Cognitive impairment in Bipolar Disorder Reversible or Treatable?

**Abstract**

Patients with bipolar disorder have impairments in cognitive functioning in several domains that persist even during euthymia. In order to understand the cognitive function trajectory, we assessed cognitive function in bipolar patients after they remitted from the first manic episode and at 6 months to 1 year intervals. Result showed that while cognitive function is impaired as early as after first manic episode remission, those that remain episode free show improvements in cognitive function. Further, in a recent single blind trial, we found that lurasidone adjunctive therapy significantly improved global cognition scores, subjective cognitive complaints and quality of life. These data demonstrate that optimal intervention in early stage bipolar disorder has the potential to reverse cognitive deficits and improve outcomes and that pharmacotherapy can reverse cognitive deficits in bipolar disorder.
